Oncology Nursing News Hosts Tweet Chat on Oncology Nursing Society's Annual Conference

Article

Oncology Nursing News® will be hosting its first tweet chat on May 23, at 1 p.m. ET, to discuss findings presented at the Oncology Nursing Society's Annual Conference, held May 17-20 in Washington, DC.

Oncology Nursing News® will be hosting its first tweet chat on May 23, at 1 p.m. ET, to discuss findings presented at the Oncology Nursing Society's (ONS) Annual Conference, held May 17-20 in Washington, DC.

“We are excited to launch the inaugural tweet chat on the oncology nursing society’s annual conference. This tweet chat will inform the audience on the highlights and news that came out of the conference,” said Michael J. Hennessy Jr., president of MJH Associates, parent company of Oncology Nursing News®.

Oncology Nursing News® welcomes all professionals within the oncology nursing specialty group to join the discussion using the hashtag #OncNurseConnect. Highlights to be discussed:

  • Clinical practice
  • Leadership management education
  • Advanced practice
  • Research
  • Professional development

Read more ONS Congress conference coverage

Recent Videos
Anne M. Reb, PhD, NP, discussing a nurse-led intervention for fear of cancer recurrence.
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
Elizabeth Burton in an interview with Oncology Nursing News
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
prostate on a yellow background

FDA Accepts New Drug Application to Darolutamide Plus ADP for mHSPC

Chris Ryan
November 22nd 2024
Article

The FDA accepted a supplemental new drug application to darolutamide plus androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

The Vitals

What New Cancer Drugs Were Approved in 2023?

Lindsay Fischer
January 1st 2024
Podcast

In this special episode of The Vitals, we ring in the New Year 2024 by combing through 2023 FDA approvals.

mental health

Palliative Care Is Underutilized, May Boost Mental Health in Pancreatic Cancer

Gina Mauro
November 21st 2024
Article

Approximately one-third of patients with pancreatic cancer and anxiety had a palliative care consultation, data showed.

The Vitals

Finley-Oliver Talks Talquetamab and Other Later Line Multiple Myeloma Therapies

Lindsay Fischer
December 14th 2023
Podcast

Beth Finley-Oliver, MSN, ARNP, AGNP-BC, recaps part of her presentation from the 2023 JADPRO meeting about caring for patients with high-risk multiple myeloma.

FDA Fast Tracks ALE.P02 for CLDN1-Poisitive Solid Cancers

FDA Fast Tracks ALE.P02 for CLDN1-Poisitive Solid Cancers

Chris Ryan
November 20th 2024
Article

The FDA granted a fast track designation to ALE-P02 for patients with CLDN1-positive squamous solid tumors.

Heather J. Jackson, PhD, APRN, FNP-BC, NEA-BC, FAANP

Rapid Taper Plays Role in Suspected Opioid Misuse in Patients With Cancer

Brielle Benyon
November 20th 2024
Article

Clinicians should consider a rapid taper approach for patients with cancer who exhibit repeated signs of opioid misuse, an expert said.

© 2024 MJH Life Sciences

All rights reserved.